# Triamcinolone acetonide-loaded chitosan-polyethylene glycol hydrogel for preventing esophageal stricture post-endoscopic submucosal dissection

**Authors:** Yaqiang Li, Rui Gao, Zhen He, Kuiliang Liu, Zujian Feng, Pingsheng Huang, Chuangnian Zhang, Haijun Hou, Baohong Xu, Jianduo An, Yan Zhao, Weiwei Wang, Shutian Zhang, Peng Li

PMC · DOI: 10.1093/rb/rbag002 · Regenerative Biomaterials · 2026-01-14

## TL;DR

A new hydrogel loaded with triamcinolone acetonide prevents esophageal stricture after endoscopic submucosal dissection, showing better healing and reduced inflammation in animal models.

## Contribution

An injectable, tissue-adhesive hydrogel system loaded with triamcinolone acetonide is developed to prevent post-ESD esophageal stricture.

## Key findings

- The hydrogel inhibited fibroblast migration and modulated macrophage polarization in vitro.
- In a porcine model, the hydrogel reduced stricture formation and improved tissue repair compared to drug or hydrogel alone.
- Histological analysis showed reduced fibrosis and inflammation in treated esophageal tissues.

## Abstract

Postoperative esophageal stricture remains a significant challenge following endoscopic submucosal dissection (ESD), with limited effective prophylactic options in clinic. Here, we report the development of an injectable and tissue-adhesive hydrogel drug delivery system composed of quaternary ammonium chitosan and polyethylene glycol (QCS-PEG), which was loaded with triamcinolone acetonide (QCS-PEG@TA), designed to mitigate post-ESD strictures. In vitro assays demonstrated that the hydrogel formulation modulated macrophage polarization and inhibited fibroblast migration. In an ESD-induced porcine esophageal stricture model, treatment with drug-encapsulated hydrogel efficiently suppressed esophageal stricture and promoted tissue repair, which were superior over drug or hydrogel alone. Histological and immunohistochemical analyses revealed that the administration of hydrogel formulation reduced fibrosis and inflammatory cell infiltration in esophageal tissues. These findings suggest that QCS-PEG@TA hydrogel provides mechanical support, inflammation-modulatory and pro-healing effects that collectively prevent stricture formation, offering a clinically translatable approach to improve therapeutic outcomes after ESD.

## Linked entities

- **Chemicals:** triamcinolone acetonide (PubChem CID 6436), polyethylene glycol (PubChem CID 9033), chitosan (PubChem CID 129662530)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, LTA (lymphotoxin alpha) [NCBI Gene 407742] {aka TNFB}, CAT (catalase) [NCBI Gene 397568], PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 396941] {aka CD31, PECAM-1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, IL1B (interleukin 1 beta) [NCBI Gene 397122] {aka IL1B1}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, CD86 (CD86 molecule) [NCBI Gene 397441]
- **Diseases:** fibrosis (MESH:D005355), inflammation (MESH:D007249), Esophageal stricture (MESH:D004940), ESD (MESH:D000784), bleeding (MESH:D006470), stenosis (MESH:D003251), restenosis (MESH:D023903), dysphagia (MESH:D003680), tendon injury (MESH:D013708), reactive epithelial hyperplasia (MESH:D017573), Cytotoxicity (MESH:D064420), esophageal perforation (MESH:D004939), mucosal (MESH:D052016), hyperplasia (MESH:D006965), esophageal cancer (MESH:D004938)
- **Chemicals:** triamcinolone (MESH:D014221), calcein AM (MESH:C085925), paraffin (MESH:D010232), oxygen (MESH:D010100), CCK- (MESH:D002766), chitosan (MESH:D048271), PI (MESH:D010716), PEG (MESH:D011092), FITC (MESH:D016650), luminal (MESH:D010634), methylene blue (MESH:D008751), water (MESH:D014867), isoflurane (MESH:D007530), silicone (MESH:D012828), H&amp;E (MESH:D006371), DMEM (-), hematoxylin (MESH:D006416), citrate (MESH:D019343), CO2 (MESH:D002245), ketamine hydrochloride (MESH:D007649), CS (MESH:D002586), DAB (MESH:C000469), H (MESH:D006859), eosin (MESH:D004801), Tween 80 (MESH:D011136), formalin (MESH:D005557), TA (MESH:D014222)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** L929 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_AR58), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), HET-1A — Homo sapiens (Human), Transformed cell line (CVCL_3702), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12915572/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12915572/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12915572/full.md

---
Source: https://tomesphere.com/paper/PMC12915572